Asia Pacific Brain Implants Market Forecast to 2030
Asia Pacific Brain Implants Market Forecast to 2030 – Regional Analysis – by Treatment [Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulator, Invasive and Non-Invasive Brain-Computer Interface, Responsive Neurostimulation for Seizures, Auditory Brainstem Implant (Retrocochlear Hearing Impairment and Cochlear Hearing Impairment), and Ophthalmic Aid/Implant], Application [Chronic Pain, Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Essential Tremor, Depression, Dystonia, Amyotrophic Lateral Sclerosis (ALS), and Neurofibromatosis 2], and End User (Hospitals and Specialized Clinics/Neurological Centers)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Strategic Initiatives by Companies Fuels Asia Pacific Brain Implants Market
Companies operating in the brain implants market constantly focus on strategic developments such as product approvals, collaborations, expansions, agreements, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the brain implants market are mentioned below: In December 2022, Abbott launched the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable SCS system available on the market for the treatment of chronic pain. The company’s portfolio of neuromodulation devices also includes Proclaim XR, the recharge-free SCS system, and Proclaim Plus featuring FlexBurst360. Brain implant manufacturers are taking steps to expand their operations around the world and launch their products in different regions, which is expected to boost the market penetration and accessibility of their offerings. Therefore, product introduction and strategic moves such as approvals, expansions, and acquisitions create significant growth opportunities in the brain implants market.
Asia Pacific Brain Implants Market Overview
The Asia Pacific brain implants market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors driving the market growth include Key factors driving the market growth are surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cords injuries. However, high cost associated with brain implant devices and procedures hinders the market growth.
China is witnessing a growing demand for innovative therapies, such as brain implants, to address complex conditions such as Parkinson’s disease and movement disorders. A 2020 study published in the BMJ Journal estimates that there are approximately 6 million Alzheimer’s disease patients in China, with the proportion of those with dementia being 5%, 11.5%, and 30% among those aged 65, 75, and 85 years, respectively.
Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Brain Implants Market Segmentation
The Asia Pacific brain implants market is segmented into treatment, application, end user, and country.
Based on treatment, the Asia Pacific brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment. The spinal cord stimulation segment held the largest share in 2022.
In terms of application, the Asia Pacific brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held the largest share in 2022.
Based on end user, the Asia Pacific brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held the largest share in 2022.
Based on country, the Asia Pacific brain implants market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific brain implants market in 2022.
Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, Renishaw Plc, and Synchron Inc are some of the leading companies operating in the Asia Pacific brain implants market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Asia Pacific brain implants market was valued at US$ 1,346.12 million in 2022 and is expected to reach US$ 3,536.70 million by 2030, registering a CAGR of 12.8% from 2022 to 2030. Surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cord injuries are among the critical factors attributed to the Asia Pacific brain implants market expansion.
As per the study “Spinal Cord Injuries,” published in May 2022, 250,000-500,000 patients worldwide suffer a spinal cord injury (SCI) yearly. According to the article “Epidemiology of traumatic spinal cord injuries: a large population-based study,” published in April 2022, the overall age-sex-standardized incidence rate of traumatic spinal cord injuries was 26.5 per 1 million population, and the rates were directly related to age in both the genders. Moreover, the incidence rate of traumatic spinal cord injuries is 59.2 per 1 million and 23.3 per 1 million in males and females, respectively, in people aged 65 and above. Spinal cord stimulators are implantable devices that help block pain signals sent from the brain. Therefore, increasing cases of spinal cord injuries fuel the demand for spinal cord stimulators, which in turn drives the growth of the brain implants market.
On the contrary, high cost associated with brain implant devices and procedures hampers the growth Asia Pacific brain implants market.
Based on treatment, the Asia Pacific brain implants market is classified into deep brain stimulation, spinal cord stimulation, vagus nerve stimulator, invasive and non-invasive brain-computer interface, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aid/implant. The spinal cord stimulation segment held 37.4% share of the Asia Pacific brain implants market in 2022, amassing US$ 503.69 million. It is projected to garner US$ 907.94 million by 2030 to expand at 7.6% CAGR during 2022-2030. Further, the auditory brainstem implant segment is bifurcated into retrocochlear hearing impairment and cochlear hearing impairment.
Based on application, the Asia Pacific brain implants market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis (ALS), and neurofibromatosis 2. The chronic pain segment held 38.4% share of the Asia Pacific brain implants market in 2022, amassing US$ 517.47 million. It is projected to garner US$ 1,306.08 million by 2030 to expand at 12.3% CAGR during 2022-2030.
Based on end user, the Asia Pacific brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held 72.1% share of the Asia Pacific brain implants market in 2022, amassing US$ 970.77 million. It is projected to garner US$ 2,722.17 million by 2030 to expand at 13.8% CAGR during 2022-2030
Based on country, the Asia Pacific brain implants market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 27.6% share of Asia Pacific brain implants market in 2022, amassing US$ 370.93 million. It is projected to garner US$ 1,030.49 million by 2030 to expand at 13.6% CAGR during 2022-2030.
Key players operating in the Asia Pacific brain implants market are Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, NeuroSky Inc, Renishaw Plc, and Synchron Inc among others.
In June 2023; Boston Scientific Corp received US Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific brain implants market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Brain Implants Market Landscape
4.1 Overview
5. Asia Pacific Brain Implants Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain-Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market – Asia Pacific Market Analysis
6.1 Overview
6.2 Asia Pacific Brain Implants Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Asia Pacific Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8.2.1 Retrocochlear Hearing Impairment
7.8.2.1.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.8.2.2 Cochlear Hearing Impairment
7.8.2.2.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market- Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson’s disease
8.4.1 Overview
8.4.2 Parkinson’s disease: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer’s disease
8.5.1 Overview
8.5.2 Alzheimer’s disease: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Asia Pacific Brain Implants Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Brain Implants Market – Country Analysis
10.1 Asia Pacific Brain Implants Market, by Key Country- Revenue, 2022 (US$ Million)
10.1.1 Asia Pacific Brain Implants Market, by Country
10.1.1.1 China
10.1.1.1.1 China: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 China: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.2.1 China: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.1.3 China: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 China: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Japan
10.1.1.2.1 Japan: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Japan: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.2.1 Japan: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.2.3 Japan: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Japan: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 India
10.1.1.3.1 India: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 India: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.2.1 India: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.3.3 India: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 India: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.4 Australia
10.1.1.4.1 Australia: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Australia: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.4.2.1 Australia: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.4.3 Australia: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.5 South Korea
10.1.1.5.1 South Korea: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 South Korea: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.5.2.1 South Korea: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.5.3 South Korea: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.6.2.1 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Brain Implants Market, by End-User, 2020-2030 (US$ Million)
11. Asia Pacific Brain Implants Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Asia Pacific Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Synchron Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 Renishaw Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NeuroSky Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Brain Implants Market Segmentation
Table 2. China: Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific Brain Implants Market, by Auditory Brainstem Implants- Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Organic Growth Strategies in Asia Pacific Brain Implants Market
Table 27. Recent Inorganic Growth Strategies in the Asia Pacific Brain Implants Market
Table 28. Glossary of Terms, Asia Pacific Brain Implants Market
LIST OF FIGURES
Figure 1. Asia Pacific Brain Implants Market Segmentation, By Country
Figure 2. Asia Pacific Brain Implants Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Brain Implants Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 6. Deep Brain Stimulation: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Spinal Cord Stimulation: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Vagus Nerve Stimulator: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Invasive and Non-Invasive Brain-Computer Interfaces: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Responsive Neurostimulation for Seizures: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Auditory Brainstem Implant: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Retrocochlear Hearing Impairment: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Ophthalmic Aids/Implant: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ophthalmic Aids/Implant: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Chronic Pain: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson’s disease: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Alzheimer’s disease: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Essential Tremor: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Depression: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Dystonia: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Amyotrophic Lateral Sclerosis (ALS): Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Neurofibromatosis 2: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 26. Hospitals: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Specialized Clinics / Neurological Centers: Asia Pacific Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Asia Pacific Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 29. Asia Pacific Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 30. China: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Japan: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. India: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Australia: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. South Korea: Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Growth Strategies in Asia Pacific Brain Implants Market
The List of Companies – Asia Pacific Brain Implants Market
1. Abbott Laboratories
2. Boston Scientific Corp
3. Medtronic Plc
4. NeuroSky Inc
5. Renishaw Plc
6. Synchron Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.